KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Tax Rate Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,052.00
Dec 31, 2025 -6,701.00
Sep 30, 2025 4,872.00
Jun 30, 2025 343.00
Mar 31, 2025 57.00
Dec 31, 2024 6,697.00
Sep 30, 2024 1,615.00
Jun 30, 2024 1,368.00
Mar 31, 2024 -9,860.00
Dec 31, 2023 1,539.00
Sep 30, 2023 -137.00
Jun 30, 2023 78.00
Mar 31, 2023 11,158.00
Dec 31, 2022 1,134.00
Sep 30, 2022 -359.00
Jun 30, 2022 -1,232.00
Mar 31, 2022 78.00
Dec 31, 2021 -9,723.00
Sep 30, 2021 629.00
Jun 30, 2021 4,052.00
Mar 31, 2021 523.00
Dec 31, 2020 9,364.00
Sep 30, 2020 163.00
Jun 30, 2020 -1,482.00
Mar 31, 2020 -62.00
Dec 31, 2019 -1,417.00
Sep 30, 2019 534.00
Jun 30, 2019 674.00
Mar 31, 2019 296.00
Dec 31, 2018 -7,259.00
Sep 30, 2018 -2,164.00
Jun 30, 2018 -1,717.00
Mar 31, 2018 -1,748.00
Dec 31, 2017 6,526.00
Sep 30, 2017 149.00
Jun 30, 2017 -457.00
Mar 31, 2017 -578.00
Dec 31, 2016 923.00
Sep 30, 2016 -412.00
Jun 30, 2016 459.00
Mar 31, 2016 -303.00
Dec 31, 2015 -74.00
Sep 30, 2015 -157.00
Jun 30, 2015 -478.00
Mar 31, 2015 300.00
Dec 31, 2014 4,364.00
Sep 30, 2014 131.00
Jun 30, 2014 145.00
Mar 31, 2014 192.00
Dec 31, 2013 -2,578.00
Sep 30, 2013 2,385.00
Jun 30, 2013 1,230.00
Mar 31, 2013 965.00